An analytical approach to acceptance criteria for quality assurance of intensity modulated radiotherapy

被引：16
|
作者：
Carver, Antony [1 ]
Gilmore, Martyn [1 ]
Riley, Stephen [1 ]
Uzan, Julien [1 ]
Mayles, Philip [1 ]
机构：
[1] Clatterbridge Ctr Oncol, Dept Phys, Bebington CH64 1SS, Merseyside, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2011年 / 100卷 / 03期
关键词：
IMRT quality assurance; PROSTATE-CANCER; IMRT;
D O I：
10.1016/j.radonc.2011.08.045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Detectability and impact of potential treatment machine errors on IMRT treatments were evaluated. The ability of the gamma index to detect deliberately introduced errors was assessed and their clinical impact was assessed using Tumour Control Probability (TCP) and Normal Tissue Complication Probability. TCP was only marginally affected by 2 mm errors in MLC position. Dose delivery errors had greater impact but were not detected as effectively using the gamma index. Acceptance criteria should include mean dose as well as gamma to help identify errors in the delivered dose. (C) 2011 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 100 (2011) 453-455
引用
收藏
页码：453 / 455
页数：3
相关论文
共 50 条
  • [1] AN ANALYTICAL APPROACH TO ACCEPTANCE CRITERIA FOR QUALITY ASSURANCE OF INTENSITY MODULATED RADIOTHERAPY
    Carver, A.
    Gilmore, M.
    Mayles, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S152 - S153
  • [2] Quality assurance methods for intensity modulated radiotherapy
    Cakir, Aydin
    Bilge, Hatice
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2013, 28 (02): : 81 - 90
  • [3] Quality assurance of intensity-modulated radiotherapy
    Low, DA
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (03) : 219 - 228
  • [4] VERIDOS: A new tool for quality assurance for intensity modulated radiotherapy
    Wiezorek, T
    Schwedas, M
    Scheithauer, M
    Salz, H
    Bellemann, M
    Wendt, TG
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (12) : 732 - 736
  • [5] Quality assurance programme for the isotoxic intensity modulated radiotherapy feasibility study
    Groom, N.
    Tsang, Y.
    Hatton, M.
    Hanna, G.
    Franks, K.
    Harden, S.
    McDonald, F.
    Harrow, S.
    Faivre-Finn, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S320 - S320
  • [6] Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer
    Boehmer, D
    Bohsung, J
    Eichwurzel, I
    Moys, A
    Budach, V
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 (03) : 319 - 325
  • [7] Quality assurance programme for the isotoxic intensity modulated radiotherapy feasibility study
    Groom, N.
    Tsang, Y.
    Hatton, M. Q.
    Hanna, G.
    Franks, K.
    Harden, S.
    McDonald, F.
    Harrow, S.
    Faivre-Finn, C.
    [J]. LUNG CANCER, 2015, 87 : S68 - S69
  • [8] Multicentre quality assurance of intensity-modulated radiotherapy planning: Beware the benchmarker
    Back, M.
    Oliver, L.
    Bromley, R.
    Eade, T.
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2008, 52 (02): : 197 - 197
  • [9] Quality assurance of intensity-modulated radiotherapy treatment planning: a dosimetric comparison
    Altaf, Saima
    Iqbal, Khalid
    Akram, Muhammad
    Buzdar, Saeed A.
    [J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2018, 17 (04) : 396 - 402
  • [10] A monitor unit verification calculation in intensity modulated radiotherapy as a dosimetry quality assurance
    Kung, JH
    Chen, GTY
    Kuchnir, FK
    [J]. MEDICAL PHYSICS, 2000, 27 (10) : 2226 - 2230
12345